Eltoukhy Helmy

Eltoukhy Helmy serves as Co-Chief Executive Officer at Guardant Health, Inc., a leading company in the healthcare sector focused on transforming cancer care through innovative genomic testing. His recent public disclosures, tracked through SEC Form 4 filings, reflect a consistent engagement with the company, with a total of 17 disclosures recorded from March 17, 2026, to July 2, 2026. The disclosures reveal a range of activities, with the largest being a grant/exercise valued at approximately $2.9 million on July 2, 2026.